Literature DB >> 22462697

Spontaneous occlusion of the circle of Willis in children: pediatric moyamoya summary with proposed evidence-based practice guidelines. A review.

Edward R Smith1, R Michael Scott.   

Abstract

Moyamoya is a progressive arteriopathy of unknown origin affecting the branches of the internal carotid artery (ICA). The arteriopathy can present as an isolated medical condition, affecting both sides of the brain ("moyamoya disease") or can be unilateral or found in association with systemic disorders ("moyamoya syndrome"). The ischemia resulting from luminal narrowing predisposes children to transient ischemic attacks and stroke-the primary presentations of affected patients. Although it is rare-affecting 1 in 1 million children in the US-moyamoya is implicated in 6% of all childhood strokes. Diagnosis is defined by characteristic findings on arteriograms, including stenosis of the branches of the ICA and a pathognomonic spray of small collateral vessels in this region, descriptively likened to a "puff of smoke" ("moyamoya" in Japanese). Treatment is predicated on restoration of cerebral blood flow by surgical revascularization. The rarity of this disorder has limited research and the development of evidence-based clinical management. While acknowledging these limitations, in this article the authors aim to summarize current studies of pediatric moyamoya, with the objective of providing a framework for construction of evidence-based guidelines for treatment. The compilation of current data in these guidelines should serve as a resource to aid pediatric neurosurgeons in their role as advocates for providing appropriate care to affected children.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22462697     DOI: 10.3171/2011.12.PEDS1172

Source DB:  PubMed          Journal:  J Neurosurg Pediatr        ISSN: 1933-0707            Impact factor:   2.375


  20 in total

1.  Atypical presentation of moyamoya disease in an infant with a de novo RNF213 variant.

Authors:  Tamar Harel; Jennifer E Posey; Brett H Graham; Magdalena Walkiewicz; Yaping Yang; Seema R Lalani; John W Belmont
Journal:  Am J Med Genet A       Date:  2015-07-21       Impact factor: 2.802

2.  CT perfusion assessment of Moyamoya syndrome before and after direct revascularization (superficial temporal artery to middle cerebral artery bypass).

Authors:  Yueqin Chen; Wenjian Xu; Xiang Guo; Zhitao Shi; Zhanguo Sun; Lingyun Gao; Feng Jin; Jiehuan Wang; Weijian Chen; Yunjun Yang
Journal:  Eur Radiol       Date:  2015-05-01       Impact factor: 5.315

Review 3.  Recent advances in moyamoya disease: pathophysiology and treatment.

Authors:  Annick Kronenburg; Kees P J Braun; Albert van der Zwan; Catharina J M Klijn
Journal:  Curr Neurol Neurosci Rep       Date:  2014-01       Impact factor: 5.081

4.  Decompressive hemicraniectomy in the management of acute stroke in children with Moyamoya disease: the difficult balance between the spontaneous postoperative revascularization process and the need for cranial reconstruction.

Authors:  Marc Hohenhaus; Mukesch Johannes Shah; Matthias Eckenweiler; Vera van Velthoven
Journal:  Childs Nerv Syst       Date:  2015-07-23       Impact factor: 1.475

Review 5.  A brief etymology of the collateral circulation.

Authors:  James E Faber; William M Chilian; Elisabeth Deindl; Niels van Royen; Michael Simons
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-10       Impact factor: 8.311

6.  Moyamoya arteriopathy.

Authors:  Edward R Smith
Journal:  Curr Treat Options Neurol       Date:  2012-12       Impact factor: 3.598

7.  A rare case of pediatric moyamoya disease with reversible white matter lesions in a 3-year-old Chinese girl.

Authors:  Shi-Jun Li; Jie Xiong; Yu He; Yang-Yang Xiao; Ding-An Mao; Li-Qun Liu
Journal:  Childs Nerv Syst       Date:  2019-11-10       Impact factor: 1.475

8.  2021 Japanese Guidelines for the Management of Moyamoya Disease: Guidelines from the Research Committee on Moyamoya Disease and Japan Stroke Society.

Authors:  Miki Fujimura; Teiji Tominaga; Satoshi Kuroda; Jun C Takahashi; Hidenori Endo; Kuniaki Ogasawara; Susumu Miyamoto
Journal:  Neurol Med Chir (Tokyo)       Date:  2022-02-22       Impact factor: 2.036

Review 9.  Diagnosis of moyamoya disease: international standard and regional differences.

Authors:  Miki Fujimura; Teiji Tominaga
Journal:  Neurol Med Chir (Tokyo)       Date:  2015-02-20       Impact factor: 1.742

Review 10.  [Advances in surgical treatment of ischemic cerebrovascular disease].

Authors:  Jianmin Zhang
Journal:  Zhejiang Da Xue Xue Bao Yi Xue Ban       Date:  2019-05-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.